291 related articles for article (PubMed ID: 7651398)
21. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase.
Ricci A; Lanfrancone L; Chiari R; Belardo G; Pertica C; Natali PG; Pelicci PG; Segatto O
Oncogene; 1995 Oct; 11(8):1519-29. PubMed ID: 7478576
[TBL] [Abstract][Full Text] [Related]
22. Direct interaction between Shc and the platelet-derived growth factor beta-receptor.
Yokote K; Mori S; Hansen K; McGlade J; Pawson T; Heldin CH; Claesson-Welsh L
J Biol Chem; 1994 May; 269(21):15337-43. PubMed ID: 8195171
[TBL] [Abstract][Full Text] [Related]
23. The role of amino acids surrounding tyrosine 1062 in ret in specific binding of the shc phosphotyrosine-binding domain.
Ishiguro Y; Iwashita T; Murakami H; Asai N; Iida K; Goto H; Hayakawa T; Takahashi M
Endocrinology; 1999 Sep; 140(9):3992-8. PubMed ID: 10465268
[TBL] [Abstract][Full Text] [Related]
24. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen.
Campbell KS; Ogris E; Burke B; Su W; Auger KR; Druker BJ; Schaffhausen BS; Roberts TM; Pallas DC
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6344-8. PubMed ID: 8022784
[TBL] [Abstract][Full Text] [Related]
25. Identification of residues within the SHC phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction.
Yajnik V; Blaikie P; Bork P; Margolis B
J Biol Chem; 1996 Jan; 271(4):1813-6. PubMed ID: 8567619
[TBL] [Abstract][Full Text] [Related]
26. The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway.
Okada S; Kao AW; Ceresa BP; Blaikie P; Margolis B; Pessin JE
J Biol Chem; 1997 Oct; 272(44):28042-9. PubMed ID: 9346957
[TBL] [Abstract][Full Text] [Related]
27. Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development.
Meisner H; Daga A; Buxton J; Fernández B; Chawla A; Banerjee U; Czech MP
Mol Cell Biol; 1997 Apr; 17(4):2217-25. PubMed ID: 9121472
[TBL] [Abstract][Full Text] [Related]
28. Tyrosine-phosphorylated low density lipoprotein receptor-related protein 1 (Lrp1) associates with the adaptor protein SHC in SRC-transformed cells.
Barnes H; Larsen B; Tyers M; van Der Geer P
J Biol Chem; 2001 Jun; 276(22):19119-25. PubMed ID: 11259429
[TBL] [Abstract][Full Text] [Related]
29. Binding of Shc to the NPXY motif is mediated by its N-terminal domain.
Prigent SA; Pillay TS; Ravichandran KS; Gullick WJ
J Biol Chem; 1995 Sep; 270(38):22097-100. PubMed ID: 7673183
[TBL] [Abstract][Full Text] [Related]
30. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity.
Lioubin MN; Algate PA; Tsai S; Carlberg K; Aebersold A; Rohrschneider LR
Genes Dev; 1996 May; 10(9):1084-95. PubMed ID: 8654924
[TBL] [Abstract][Full Text] [Related]
31. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.
Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE
Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245
[TBL] [Abstract][Full Text] [Related]
32. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE
J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797
[TBL] [Abstract][Full Text] [Related]
33. N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway.
Nakamura T; Sanokawa R; Sasaki Y; Ayusawa D; Oishi M; Mori N
Oncogene; 1996 Sep; 13(6):1111-21. PubMed ID: 8808684
[TBL] [Abstract][Full Text] [Related]
34. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.
Liu SK; McGlade CJ
Oncogene; 1998 Dec; 17(24):3073-82. PubMed ID: 9872323
[TBL] [Abstract][Full Text] [Related]
35. An epidermal growth factor receptor-leukocyte tyrosine kinase chimeric receptor generates ligand-dependent growth signals through the Ras signaling pathway.
Ueno H; Hirano N; Kozutsumi H; Sasaki K; Tanaka T; Yazaki Y; Hirai H
J Biol Chem; 1995 Aug; 270(34):20135-42. PubMed ID: 7650032
[TBL] [Abstract][Full Text] [Related]
36. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation.
Blaikie PA; Fournier E; Dilworth SM; Birnbaum D; Borg JP; Margolis B
J Biol Chem; 1997 Aug; 272(33):20671-7. PubMed ID: 9252386
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
Gill K; Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
[TBL] [Abstract][Full Text] [Related]
38. The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor.
Batzer AG; Blaikie P; Nelson K; Schlessinger J; Margolis B
Mol Cell Biol; 1995 Aug; 15(8):4403-9. PubMed ID: 7542744
[TBL] [Abstract][Full Text] [Related]
39. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc.
Dilworth SM; Brewster CE; Jones MD; Lanfrancone L; Pelicci G; Pelicci PG
Nature; 1994 Jan; 367(6458):87-90. PubMed ID: 7509037
[TBL] [Abstract][Full Text] [Related]
40. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor.
Hayashi H; Ichihara M; Iwashita T; Murakami H; Shimono Y; Kawai K; Kurokawa K; Murakumo Y; Imai T; Funahashi H; Nakao A; Takahashi M
Oncogene; 2000 Sep; 19(39):4469-75. PubMed ID: 11002419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
